Professional Documents
Culture Documents
2:19=2
10:00
100% 10:95%
From the results of FT-IR and 1H-NMR, it could be con-
rmed that the synthesis of CSMPEG was the target
compounds.
X-ray diffraction analysis
The X-ray diffraction diagrams of CS, MPEG, MPEG
CDM, and the CSMPEG were shown in Fig. 4. The
spectra of MPEG and MPEGCDE are basically the same,
but with the CS and CSMPEG were greatly different: the
diffraction peaks were shown for CSMPEG in 2h (angle
of 31.7 and 56.5, respectively), which were not existed
for the CS and MPEG, and the crystal spacing d was
0.28 nm (relative abundance 23.3%) and 0.16 (relative
abundance 3.7%) respectively. At the same time, the rel-
ative abundance of the diffraction peaks for CSMPEG in
the 45.2 was increased from 1.85 to 14.3%. All of the
above indicated that due to the introduction of MPEG for
the synthesis of new compounds, and the formation of a
new intramolecular hydrogen bonds, so that the crystalli-
zation of chitosan molecules and the ordered structure of
the original were changed, crystallinity were increased, and
solubility were decreased, indicating that the material CS is
Table 1 Elementary analysis of MPEGCDM
Element Theoretical value (%) Observed value (%)
C 54.36 54.42
H 9.04 9.17
N 0.55 0.57
Mol Biol Rep (2011) 38:24552462 2457
1 3
more conducive to co-precipitation methods such as prep-
aration of NP [30, 31].
DSC analysis
CS, MPEG, physical mixture of CS and MPEG, and
CSMPEG for differential scanning calorimetry analysis,
the results were shown in Fig. 5. It can be seen from the
diagram, for the physical mixture of CS and MPEG, the
peak location and peak area of 100.9C endothermic peak
(peak area 173.8 J/g) of CS and 63.1C endothermic
peak (peak area 151.0 J/g) of MPEG did not change. For
the CSMPEG, the location and peak area of 100.9C
endothermic peak (peak area 173.6 J/g) of CS was
unchanged, but 63.1C endothermic peak of MPEG was
moved to the left of 57.2C (peak area 243.6 J/g).
According to the grafting rate of 10.95%, the theoretical
peak area of the endothermic peak of CS and MPEG was
156.8 J/g with much smaller than the peak area of CS and
MPEG in the CSMPEG (417.2 J/g). The results showed
that the degree of crystallinity for the CSMPEG was much
higher than the physical mixture of CS and MPEG, which
was consistent with the results of X-ray diffraction.
Synthesis of CSMPEG and the grafting rate
The testing methods of PEGNH2 with a compound in the
former literature of were through the trinitrobenzene sul-
fonic acid (TNBS), uorescamine, gel permeation chro-
matography (GPC), capillary zone electrophoresis (CE),
Fig. 1 FT-IR spectrum of
MPEG (a) and MPEGCDM (b)
2458 Mol Biol Rep (2011) 38:24552462
1 3
matrix-assisted laser desorption mass spectrometry
(MALDI-MS), Raman spectra, Fourier transform infrared
spectroscopy (FT-IR), and so on. As the limitations of
methods and equipment, etc., the most commonly used
method of measurement is mainly the TNBS method. This
method is an indirect method by determining the reduction
in the number of NH2 to calculate the degree of activation
or modication, but NH2 in the solution have been con-
cealed or TNBS was inaccessible to the sites of free amino,
so the determination of the accuracy of this method is poor.
Meanwhile, the accuracy of TNBS method was also
affected by the interference of polyethylene glycol, and
must separate out the free polyethylene glycol to
re-determinate it. In addition, this method requires a
quantitative reaction under the alkaline conditions. If the
reactants were not dissolved in the solution of alkaline
(e.g., CS), the determination is meaningless. With refer-
ence to the former literatures [32], by using two-phase
system spectrophotometric to determinate the concentra-
tion of free polyethylene glycol, then calculating the
grafting rate in an indirect method. After the inspection, the
determined results of CS, CDM, and CSMPEG were not
interfered. After several batches of samples were mea-
sured, the results of indirect method, the weight of law and
the
1
HNMR measurement are consistent with each other
with both 1011%. Therefore, the two methods are suitable
methods for the determination of the grafting rate of
polymer.
Fig. 2 FT-IR spectrum of CS
(a) and CSMPEG (b)
Mol Biol Rep (2011) 38:24552462 2459
1 3
Conclusion
In conclusion, with CS (MW 200000, de-acetyl rate [99%)
and MPEG5000 as the materials, MPEG was activated by
1,1
0
carbonyldiimidazole. This reaction was gentle and
usually was used in protein-PEG. The activated MPEG was
made with activation rate of 109% by choosing the best
solvent, ratio of materials and reaction time, and the sol-
ubility or activation rate and recovery rate were used as the
guidelines. Then, the activated MPEG reacted with primary
amino groups of chitosan and the graft copolymer of
chitosanMPEG was obtained through two steps by
choosing the best solvent, reaction temperature, reaction
time and ratio of materials and with the graft rate, deter-
mined by gravimetric method and indirect method, as the
guidelines. The structure of the copolymer was identied
with FT-IR,
1
H-NMR and graft rate of the copolymer was
determine to be 11% by gravimetric method, indirect
method and
1
H-NMR. The graft rate agreed with the PEG
content of classical stealth nanoparticles materials. X-ray
Fig. 3 1H-NMR spectrum of
CS (a), MPEG (b), and
CSMPEG (c)
2460 Mol Biol Rep (2011) 38:24552462
1 3
diffraction and DSC proved that the crystallinity of the
copolymer raised and the copolymer had a tendency to
form self-assembling micelle [913]. The copolymer was
stable at room temperature and was a promising carrier for
stealthy micelle nanoparticles [5, 1827]. It was not
reported at home and overseas that the graft copolymer of
CSMPEG, with the PEG content of classical stealth
nanoparticles materials, was synthesized through two steps.
The synthesis of CSMPEG graft copolymer is expected to
become the carrier of stealth nanoparticles, and it will be
benet for long-circulating drug delivery systems, and
provide the solid foundation for tumor research in the
future.
References
1. Basu SK (1990) Receptor-mediated endocytosis of macromo-
lecular conjugates in selective drug delivery. Biochem Pharmacol
40:19411946
2. Putnam D, Kopecek J (1995) Polymer conjugates with anticancer
activity. Adv Polym Sci 122:55123
3. Duncan R, Dimitrijevic S, Evagorou EG (1996) The role of
polymer conjugates in the diagnosis and treatment of cancer. STP
Pharma Sci 6:237263
4. Yokoyama M (1992) Block copolymers as drug carriers. Crit Rev
Ther Drug Carrier Syst 9:213248
5. Kwon CS, Kataoka K (1995) Block copolymer micelles as long-
circulating drug vehicles. Adv Drug Deliv Rev 16:295309
6. Dowling KC, Thomas JK (1990) A novel micellar synthesis and
photophysical characterization of water-soluble acrylamidesty-
rene block copolymers. Macromolecules 23:10591064
7. Astaeva I, Zhong XF, Eisenberg A (1993) Critical micellization
phenomena in block polyelectrolyte solutions. Macromolecules
26:73397352
8. Gao Z, Eisenberg A (1993) A model of micellization for block
copolymers in solutions. Macromolecules 26:73537360
9. Torchin VP (2001) Structure and design of polymeric surfactant
based drug delivery systems. J Control Release 73:137172
10. Sakuma S, Hayashi M, Akashi M (2001) Design of nanoparticles
composed of graft copolymers for oral peptide delivery. Adv
Drug Deliv Rev 47:2137
11. Tatsuro O, Hidetoshi N, Yuichi O (1998) Aggregation phenom-
enon of PEG-grafted chitosan in aqueous solution. Polymer
39:51715175
12. Nakashima K, Tango M, Araki K, Takeuchi K (2002) Room
temperature phosphorescence of 6-bromo-2-naphthol in micelles
of poly(ethylene oxide)poly(propylene oxide)poly(ethylene
oxide) block copolymers and in their mixed aggregates with
sodium dodecyl sulfate. Spectrochimica Acta Part A. Mol Biomol
Spectrosc 58:123128
13. Kakizawa Y, Kataoka K (2002) Block copolymer micelles for
delivery of gene and related compounds. Adv Drug Deliv Rev
54:203222
14. Attwood D, Florence AT (eds) (1983) Surfactant systems.
Chapman and Hall, London
15. Kwon G, Suwa S, Yokoyama M, Okano T, Sakurai Y, Kataoka K
(1994) Enhanced tumor accumulation and prolonged circulation
times of micelle-forming poly(ethylene oxide-aspartate) block
copolymer-adriamycin conjugates. J Control Release 29:1723
16. Nishiyama N, Kataoka K (2001) Preparation and characterization
of size-controlled polymeric micelle containing cis-dichlor-
odiammineplatium(II) in the core. J Control Release 74:8394
17. Kabanov AV, Batrakova EV, Alakhov VY (2002) Pluronic block
copolymers as novel polymer therapeutics for drug and gene
delivery. J Control Release 82:189212
18. Maeda H, Seymour LW, Miyamoto Y (1992) Conjugates of
anticancer agents and polymers: advantages of macromolecular
therapeutics in vivo. Bioconjug Chem 3:351362
19. Jain RK (1997) Delivery of molecular and cellular medicine to
solid tumors. Adv Drug Deliv Rev 26:7190
20. Truberskoy VS, Torchilin VP (1996) Polyethyleneglycol based
micelles as carriers of therapeutic and diagnostic agents. STP
Pharma Sci 6:7986
21. Osada K, Christie RJ, Kataoka K (2009) Polymeric micelles from
poly(ethylene glycol)-poly(amino acid) block copolymer for drug
and gene delivery. J R Soc Interface 3:S325S339
22. Yokoyama M, Okano T, Sakurai Y, Suwa S, Kataoka K (1996)
Introduction of cisplatin into polymeric micelle. J Control
Release 39:351356
Fig. 5 DSC spectra of the CS (a), MPEG (b), physical mixture of CS
and MPEG (c), and CSMPEG (d)
Fig. 4 The X-ray diffraction diagrams of CS (a), MPEG (b), MPEG
CDM (c), and the CSMPEG (d)
Mol Biol Rep (2011) 38:24552462 2461
1 3
23. Kim SC, Kim DW, Shim YH, Bang JS, Oh HS (2001) In vivo
evaluation of polymeric micellar paclitaxel formulation: toxicity
and efcacy. J Control Release 72:191202
24. Kataoka K, Matsumoto T, Yokoyama M, Okano T, Sakurai Y,
Fukushima S, Okamoto K, Kwon GS (2000) Doxorubucin-loaded
poly(ethylene glycol)-poly(b-benzyl-L-aspartate) copolymer
micelles: their pharmaceutical characteristics and biological sig-
nicance. J Control Release 64:143153
25. Kwonm GS, Naito M, Yokoyama M, Okano T, Sakurai Y,
Kataoka K (1995) Physical entrapment of Adriamycin in AB
block copolymer micelles. Pharm Res 12:192195
26. Yokoyama M, Fukushima S, Uehara R, Okamoto K, Kataoka K,
Sakurai Y, Okano T (1998) Characterization of physical entrap-
ment and chemical conjugation of Adriamycin in polymeric
micelles and their design for in vivo delivery to a solid tumor.
J Control Release 50:7992
27. Yu BG, Okano T, Kataoka K, Sardari S, Kwon GS (1998) In vitro
dissociation of antifungal efcacy and toxicity for amphotericin
B-loaded poly(ethylene oxide)-block- poly(b-benzyl-L-aspartate)
micelles. J Control Release 56:285291
28. Beauchamp CO, Gonias SL, Menapace DP, Pizzo SV (1983) A
new procedure for the synthesis of polyethylene glycol-protein
adducts; effects on function, receptor recognition, and clearance
of superoxide dismutase, lactoferrin, and alpha 2-macroglobulin.
Anal Biochem 131:2533
29. Li W, Zheng C, Zhang D (2001) Modication of bovine serum
albumin with polyethylene glycol derivative and related analysis
techniques. Lett Biotechnol 12:164166
30. Peracchia MT, Fattal E, Desmaele D (1999) Stealth PEGylalted
polycyanoacrylate nanoparticles for intravenous adminstration
and splenic targeting. J Control Release 60:121130
31. Gref R, Ialek M, Qudlee P (2000) Stealth corona-core nano-
particles surface modied by polyethylene glycol(PEG): inu-
ences of the corona (PEG chain length and surface density) and of
the core composition on phagocytic uptake and plasma protein
adsorption. Colloids Surf B Biointerfaces 18:301308
32. Gao R, Jiang Z (2003) A two-phase system spectrophotometric
method for determination polyethylene glycol in pegylated pro-
tein mixtures. Chin J Anal Lab 22:4446
2462 Mol Biol Rep (2011) 38:24552462
1 3